| News

Synendos Therapeutics awarded EU funding

29.07.2019

Synendos Therapeutics AG with headquarters in Allschwil is benefiting from the financial support for which small and medium-sized enterprises can apply within the framework of Horizon 2020, a program launched by the EU. The pharma company is also supported by the start-up accelerator BaseLaunch.

Andrea Chicca, Co-founder & CEO of Synendos Therapeutics (img. Mathias Mangold)

Synendos Therapeutics AG, a company headquartered in Switzerland Innovation Park Basel Area, is developing a new class of molecules. The pharma firm intends to use these to treat anxiety and other stress related disorders. The accelerator BaseLaunch has already included the start-up in Phase II of the program. BaseLaunch is handled by BaselArea.swiss, which also manages the Switzerland Innovation Park Basel Area. Now, the European Union (EU) has also rewarded the innovative approach pursued by Synendos Therapeutics, as outlined by an article from startupticker.ch.

Synendos has been chosen among a total of 22 Swiss start-ups for the first phase of the SME program linked to Horizon 2020. This entails financial support in the form of a grant worth 50,000 euros. Moreover, these companies can then also opt to apply for Phase II, in which participating companies can receive grants of between 0.5 million and 2.5 million euros in order to launch pilot projects or grow their business.

ABBA Therapeutics from Basel also made it into the first phase of the program. The company develops antibodies aimed at helping to fight cancer. With its approach, it has also already achieved Phase I of BaseLaunch.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

Basel Area – exactly the right chemistry for South Korean pharma companies
Basel Area Business & Innovation, Innovation, Invest

Basel Area – exactly the right chemistry for South Korean pharma companies

KPBMA and Basel Area Business & Innovation establish tailored collaboration to support Korean biopharmaceutical companies to enter the European market

Read More
Basel Area supporting three digital health startups
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

Basel Area supporting three digital health startups

Basel Area Business & Innovation will be offering intensive support to the three winners of its DayOne Digital Health Accelerator...

Read More
Gray establishes presence in Basel
Basel Area Business & Innovation, Innovation, Invest

Gray establishes presence in Basel

The North American fully integrated specialty service provider Gray has established a subsidiary in Basel. The key factors in favor...

Read More
Artificial Intelligence able to identify potentially life-saving antibiotics
Basel Area Business & Innovation, Innovation, Invest

Artificial Intelligence able to identify potentially life-saving antibiotics

A computer algorithm has identified antibiotics that that are still effective against infections in which multi-resistant germs are present. University...

Read More
Investors give Anaveon 110 million Swiss francs
Basel Area Business & Innovation, Innovation, Invest

Investors give Anaveon 110 million Swiss francs

Anaveon has received investment commitments amounting to 110 million Swiss francs in a Serie B funding round. The Basel-based biopharmaceutical...

Read More
Basel alliance seeks to combat antibiotic resistance
Basel Area Business & Innovation, Innovation, Invest

Basel alliance seeks to combat antibiotic resistance

The Spearhead alliance has been founded in Basel with the aim of combating the silent pandemic of antimicrobial resistance. By...

Read More
Kinarus and Noorik awarded federal grants
Basel Area Business & Innovation, Innovation, Invest

Kinarus and Noorik awarded federal grants

The Basel-based biopharmaceutical companies Kinarus and Noorik have been awarded federal grants for their clinical trials investigating drug candidates to...

Read More
Alloy acquires deepCDR and will expand Basel site
Basel Area Business & Innovation, Innovation, Invest

Alloy acquires deepCDR and will expand Basel site

Alloy Therapeutics, a biotechnology firm from Boston in the USA, has acquired the Basel-based startup deepCDR Biologics. Alloy labs and...

Read More
Basel Healthtech fund successfully closed
Basel Area Business & Innovation, Innovation, Invest

Basel Healthtech fund successfully closed

The venture capital firm MTIP has announced the successful closing of its FUND II. It is one of the first...

Read More
Roche tests able to detect Omicron
Basel Area Business & Innovation, Innovation, Invest

Roche tests able to detect Omicron

The Roche subsidiary TIB Molbiol has developed new coronavirus testing kits that can also detect the new Omicron variant of...

Read More
1 2 3 31

Do you have a question? We'd like to hear from you.